Monograph Wealth Advisors, LLC Ardelyx, Inc. Transaction History
Monograph Wealth Advisors, LLC
- $653 Million
- Q1 2024
A detailed history of Monograph Wealth Advisors, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Monograph Wealth Advisors, LLC holds 50,000 shares of ARDX stock, worth $275,500. This represents 0.06% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$275,500% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding ARDX
# of Institutions
200Shares Held
141MCall Options Held
1.25MPut Options Held
1.52M-
Janus Henderson Group PLC London, X022MShares$121 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.1MShares$94.2 Million0.0% of portfolio
-
State Street Corp Boston, MA14.1MShares$77.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$73.8 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.81MShares$37.5 Million0.8% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $852M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...